379 related articles for article (PubMed ID: 28688841)
1. How MR1 Presents a Pathogen Metabolic Signature to Mucosal-Associated Invariant T (MAIT) Cells.
McWilliam HEG; Villadangos JA
Trends Immunol; 2017 Sep; 38(9):679-689. PubMed ID: 28688841
[TBL] [Abstract][Full Text] [Related]
2. MR1 antigen presentation to MAIT cells: new ligands, diverse pathways?
McWilliam HE; Villadangos JA
Curr Opin Immunol; 2018 Jun; 52():108-113. PubMed ID: 29754112
[TBL] [Abstract][Full Text] [Related]
3. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
4. MAIT cells and MR1-antigen recognition.
Keller AN; Corbett AJ; Wubben JM; McCluskey J; Rossjohn J
Curr Opin Immunol; 2017 Jun; 46():66-74. PubMed ID: 28494326
[TBL] [Abstract][Full Text] [Related]
5. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
[TBL] [Abstract][Full Text] [Related]
6. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
Corbett AJ; Awad W; Wang H; Chen Z
Front Immunol; 2020; 11():1961. PubMed ID: 32973800
[TBL] [Abstract][Full Text] [Related]
7. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
8. Human TRAV1-2-negative MR1-restricted T cells detect S. pyogenes and alternatives to MAIT riboflavin-based antigens.
Meermeier EW; Laugel BF; Sewell AK; Corbett AJ; Rossjohn J; McCluskey J; Harriff MJ; Franks T; Gold MC; Lewinsohn DM
Nat Commun; 2016 Aug; 7():12506. PubMed ID: 27527800
[TBL] [Abstract][Full Text] [Related]
9. Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil.
Ciacchi L; Mak JYW; Le JP; Fairlie DP; McCluskey J; Corbett AJ; Rossjohn J; Awad W
J Biol Chem; 2024 May; 300(5):107229. PubMed ID: 38537698
[TBL] [Abstract][Full Text] [Related]
10. The Diverse Family of MR1-Restricted T Cells.
Gherardin NA; McCluskey J; Rossjohn J; Godfrey DI
J Immunol; 2018 Nov; 201(10):2862-2871. PubMed ID: 30397170
[TBL] [Abstract][Full Text] [Related]
11. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
Keller AN; Eckle SB; Xu W; Liu L; Hughes VA; Mak JY; Meehan BS; Pediongco T; Birkinshaw RW; Chen Z; Wang H; D'Souza C; Kjer-Nielsen L; Gherardin NA; Godfrey DI; Kostenko L; Corbett AJ; Purcell AW; Fairlie DP; McCluskey J; Rossjohn J
Nat Immunol; 2017 Apr; 18(4):402-411. PubMed ID: 28166217
[TBL] [Abstract][Full Text] [Related]
12. The intracellular pathway for the presentation of vitamin B-related antigens by the antigen-presenting molecule MR1.
McWilliam HE; Eckle SB; Theodossis A; Liu L; Chen Z; Wubben JM; Fairlie DP; Strugnell RA; Mintern JD; McCluskey J; Rossjohn J; Villadangos JA
Nat Immunol; 2016 May; 17(5):531-7. PubMed ID: 27043408
[TBL] [Abstract][Full Text] [Related]
13. Expression and trafficking of MR1.
Lamichhane R; Ussher JE
Immunology; 2017 Jul; 151(3):270-279. PubMed ID: 28419492
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens.
McWilliam HEG; Mak JYW; Awad W; Zorkau M; Cruz-Gomez S; Lim HJ; Yan Y; Wormald S; Dagley LF; Eckle SBG; Corbett AJ; Liu H; Li S; Reddiex SJJ; Mintern JD; Liu L; McCluskey J; Rossjohn J; Fairlie DP; Villadangos JA
Proc Natl Acad Sci U S A; 2020 Oct; 117(40):24974-24985. PubMed ID: 32958637
[TBL] [Abstract][Full Text] [Related]
15. TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells.
Ussher JE; van Wilgenburg B; Hannaway RF; Ruustal K; Phalora P; Kurioka A; Hansen TH; Willberg CB; Phillips RE; Klenerman P
Eur J Immunol; 2016 Jul; 46(7):1600-14. PubMed ID: 27105778
[TBL] [Abstract][Full Text] [Related]
16. MAIT Cells in Health and Disease.
Magalhaes I; Solders M; Kaipe H
Methods Mol Biol; 2020; 2098():3-21. PubMed ID: 31792812
[TBL] [Abstract][Full Text] [Related]
17. Production of MR1 Tetramers Loaded with Microbial Ligands.
Ladd NA; Froyd CA; Adams EJ
Methods Mol Biol; 2020; 2098():191-207. PubMed ID: 31792824
[TBL] [Abstract][Full Text] [Related]
18. MR1 presentation of vitamin B-based metabolite ligands.
McWilliam HE; Birkinshaw RW; Villadangos JA; McCluskey J; Rossjohn J
Curr Opin Immunol; 2015 Jun; 34():28-34. PubMed ID: 25603223
[TBL] [Abstract][Full Text] [Related]
19. Understanding and modulating the MR1 metabolite antigen presentation pathway.
McWilliam HEG; Salio M
Mol Immunol; 2021 Jan; 129():121-126. PubMed ID: 33293099
[TBL] [Abstract][Full Text] [Related]
20. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
Lepore M; Lewinsohn DA; Lewinsohn DM
Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
